title: Infliximab vs adalimumab for Crohn's disease.
authors: Department of Gastroenterology, Tunbridge Wells Hospital, Kent, United Kingdom.
authors: Angad S
authors: AS
authors: Dhillon
authors: Department of Gastroenterology, Tunbridge Wells Hospital, Kent, United Kingdom.
authors: Adam W
authors: AW
authors: Harris
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D003424:Crohn Disease / Q000188:drug therapy*; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008297:Male
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D005765:Gastrointestinal Agents; D007155:Immunologic Factors